A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media

Molecular Immunology

Volumn 44, Issue 9, 2007, Pages 2446-2458

  McGillivary, Glen ^a   Ray, William C ^a   Bevins, Charles L ^b   Munson Jr , Robert S ^a   Bakaletz, Lauren O ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobial peptide; Cathelicidin; M. catarrhalis; NTHI; RSV; S. pneumoniae

Indexed keywords

CATHELICIDIN; COMPLEMENTARY DNA; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN; RECOMBINANT PROTEIN;

ADENOVIRUS; ALPHA HELIX; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUDITORY TUBE; BACTERIAL VIRULENCE; CHINCHILLA; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; EPITHELIUM CELL; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HAEMOPHILUS INFLUENZAE; IN SITU HYBRIDIZATION; INFLUENZA VIRUS A; INNATE IMMUNITY; MIDDLE EAR; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OTITIS MEDIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; QUANTITATIVE ASSAY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURAL PROTEOMICS; UPPER RESPIRATORY TRACT; VIRUS VIRULENCE;

ADENOVIRIDAE; BACTERIA (MICROORGANISMS); INFLUENZA A VIRUS; MORAXELLA CATARRHALIS; RICE STRIPE VIRUS; STREPTOCOCCUS PNEUMONIAE;

EID: 33846213594     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.10.008     Document Type: Article

References (74)

1. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., and Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96 (2000) 3086-3093
2. Agerberth B., Gunne H., Odeberg J., Kogner P., Boman H.G., and Gudmundsson G.H. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 195-199
3. Alsarraf R., Jung C.J., Perkins J., Crowley C., Alsarraf N.W., and Gates G.A. Measuring the indirect and direct costs of acute otitis media. Arch. Otolaryngol. Head Neck Surg. 125 (1999) 12-18
4. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K. Current Protocols in Molecular Biology (1993), John Wiley & Sons, Inc.
5. Bakaletz L.O. Otitis Media. In: Brogden K.A., and Guthmiller J.M. (Eds). Polymicrobial Diseases (2002), ASM Press, Washington, DC 259-298
6. Bakaletz L.O. Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla. Infect. Immun. 63 (1995) 4188-4190
7. Bals R., Wang X., Zasloff M., and Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 9541-9546
8. Bals R., Weiner D.J., Meegalla R.L., and Wilson J.M. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J. Clin. Invest. 103 (1999) 1113-1117
9. Bergman P., Johansson L., Asp V., Plant L., Gudmundsson G.H., Jonsson A.B., and Agerberth B. Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol. 7 (2005) 1009-1017
10. Bergman P., Termen S., Johansson L., Nystrom L., Arenas E., Jonsson A.B., Hokfelt T., Gudmundsson G.H., and Agerberth B. The antimicrobial peptide rCRAMP is present in the central nervous system of the rat. J. Neurochem. 5 (2005) 1132-1140
11. Brogden K.A., Kalfa V.C., Ackermann M.R., Palmquist D.E., McCray Jr. P.B., and Tack B.F. The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob. Agents Chemother. 45 (2001) 331-334
12. Cassell, G.H., 1997. New and Reemerging Infectious Diseases: A Global Crisis and Immediate Threat to the Nation's Health: The Role of Research. Washington, DC, pp. 1-11.
13. Cassell, G.H., Archer, G.L., Beam, T.R., Gilchrist, M.J., Goldmann, D., Hooper, D.C., Jones, R.N., Kleven, S.H., Lederberg, J., Levy, S.B., Lein, D.H., Moellering, R.C., O'Brien, T.F., Osburn, B., Osterholm, M., Shlaes, D.M., Terry, M., Tolin, S.A., Tomasz, A., 1994. Report of the ASM Task Force on Antibiotic Resistance. Washington, DC.
14. Chen C., Brock R., Luh F., Chou P.J., Larrick J.W., Huang R.-F., and Huang T.-H. The solution structure of the active domain of CAP18-a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett. 370 (1995) 46-52
15. Davidson D.J., Currie A.J., Reid G.S., Bowdish D.M., MacDonald K.L., Ma R.C., Hancock R.E., and Speert D.P. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172 (2004) 1146-1156
16. De Y., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., and Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192 (2000) 1069-1074
17. Dorschner R.A., Pestonjamasp V.K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., Agerberth B., Gudmundsson G.H., and Gallo R.L. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117 (2001) 91-97
18. Duits L.A., Nibbering P.H., van Strijen E., Vos J.B., Mannesse-Lazeroms S.P., van Sterkenburg M.A., and Hiemstra P.S. Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol. Med. Microbiol. 38 (2003) 59-64
19. Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur. J. Pediatr. 160 (2001) 407-413
20. Gallo R.L., Kim K.J., Bernfield M., Kozak C.A., Zanetti M., Merluzzi L., and Gennaro R. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem. 272 (1997) 13088-13093
21. Giebink G.S., Berzins I.K., Marker S.C., and Schiffman G. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect. Immun. 30 (1980) 445-450
22. Giebink G.S., Ripley M.L., and Wright P.F. Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla. Ann. Otol. Rhinol. Laryngol. 96 (1987) 199-206
23. Gitiban N., Jurcisek J.A., Harris R.H., Mertz S.E., Durbin R.K., Bakaletz L.O., and Durbin J.E. Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus. J. Virol. 79 (2005) 6035-6042
24. Gough M., Hancock R.E., and Kelly N.M. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 64 (1996) 4922-4927
25. Gudmundsson G.H., and Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J. Immunol. Methods 232 (1999) 45-54
26. Hancock R.E., and Scott M.G. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 8856-8861
27. Harris R.H., Wilk D., Bevins C.L., Munson Jr. R.S., and Bakaletz L.O. Identification and characterization of a mucosal antimicrobial peptide expressed by the chinchilla (Chinchilla lanigera) airway. J. Biol. Chem. 279 (2004) 20250-20256
28. Harrison A., Dyer D.W., Ray W.C., Mungur R., Carson M.B., Zhong H., Gipson J., Gipson M., Johnson L.S., Lewis L., Bakaletz L.O., and Munson Jr. R.S. Genomic sequence of an otitis media isolate of nontypeable Haemophilus influenzae: comparative study with H. infleunzae serotype d strain KW20. J. Bacteriol. 13 (2005) 4627-4636
29. Hausdorff W.P., Yothers G., Dagan R., Kilpi T., Pelton S.I., Cohen R., Jacobs M.R., Kaplan S.L., Levy C., Lopez E.L., Mason E.O., Syriopoulou V., Wynne B., and Bryant J. Multinational study of penumococcal serotypes causing acute otitis media in children. Pediatr. Infec. Dis. J. 21 (2002) 1008-1016
30. Heikkinen T., and Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin. Microbiol. Rev. 16 (2003) 230-241
31. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., and Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7 (2001) 180-185
32. Johansson J., Gudmundsson G.H., Rottenberg M.E., Berndt K.D., and Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273 (1998) 3718-3724
33. Kaplan B., Wandstrat T.L., and Cunningham J.R. Overall cost in the treatment of otitis media. Pediatr. Infect. Dis. J. 16 (1997) S9-S11
34. Kennedy B.J., Novotny L.A., Jurcisek J.A., Lobet Y., and Bakaletz L.O. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge. Infect. Immun. 68 (2000) 2756-2765
35. Kim S.T., Cha H.E., Kim D.Y., Han G.C., Chung Y.S., Lee Y.J., Hwang Y.J., and Lee H.M. Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol. 123 (2003) 81-85
36. Kurosaka K., Chen Q., Yarovinsky F., Oppenheim J.J., and Yang D. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 10 (2005) 6257-6265
37. Larrick J.W., Hirata M., Balint R.F., Lee J., Zhong J., and Wright S.C. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63 (1995) 1291-1297
38. Larrick J.W., Morgan J.G., Palings I., Hirata M., and Yen M.H. Complementary DNA sequence of rabbit CAP18-a unique lipopolysaccharide binding protein. Biochem. Biophys. Res. Commun. 179 (1991) 170-175
39. Lehrer R.I., and Ganz T. Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 9 (2002) 18-22
40. Lehrer R.I., and Ganz T. Defensins of vertebrate animals. Curr. Opin. Immunol. 14 (2002) 96-102
41. Lysenko E.S., Gould J., Bals R., Wilson J.M., and Weiser J.N. Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect. Immun. 68 (2000) 1664-1671
42. McCullers J.A., and Rehg J.E. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J. Infect. Dis. 186 (2002) 341-350
43. Monto A.S., and Ullman B.M. Acute respiratory illness in an American community. The Tecumseh study. JAMA 227 (1974) 164-169
44. Mygind P.H., Fischer R.L., Schnorr K.M., Hansen M.T., Sonksen C.P., Ludvigsen S., Raventos D., Buskov S., Christensen B., De Maria L., Taboureau O., Yaver D., Elvig-Jorgensen S.G., Sorensen M.V., Christensen B.E., Kjaerulff S., Frimodt-Moller N., Lehrer R.I., Zasloff M., and Kristensen H. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437 (2005) 975-980
45. Nagaoka I., Tsutsumi-Ishii Y., Yomogida S., and Yamashita T. Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation. J. Biol. Chem. 272 (1997) 22742-22750
46. Nakamura A., DeMaria T.F., Lim D.J., and van Blitterswijk C.A. Primary culture of chinchilla middle ear epithelium. Ann. Otol. Rhinol. Laryngol. 100 (1991) 774-782
47. Nakamura A., DeMaria T.F., van Blitterswijk C., and Lim D.J. Effect of endotoxin on cultured chinchilla middle ear epithelium. Ann. Otol. Rhinol. Laryngol. 101 (1992) 607-611
48. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R.A., Pestonjamasp V., Piraino J., Huttner K., and Gallo R.L. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414 (2001) 454-457
49. Plotkowski M.C., Puchelle E., Beck G., Jacquot J., and Hannoun C. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am. Rev. Respir. Dis. 134 (1986) 1040-1044
50. Polack F.P., Irusta P.M., Hoffman S.J., Schiatti M.P., Melendi G.A., Delgado M.F., Laham F.R., Thumar B., Hendry R.M., Melero J.A., Karron R.A., Collins P.L., and Kleeberger S.R. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8996-9001
51. Proud D., Sanders S.P., and Wiehler S. Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J. Immunol. 172 (2004) 4637-4645
52. Ritonja A., Kopitar M., Jerala R., and Turk V. Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett. 255 (1989) 211-214
53. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual. third ed. (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor
54. Sorensen O.E., Cowland J.B., Theilgaard-Monch K., Liu L., Ganz T., and Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol. 170 (2003) 5583-5589
55. Sorensen O.E., Follin P., Johnsen A.H., Calafat J., Tjabringa G.S., Hiemstra P.S., and Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97 (2001) 3951-3959
56. Sorensen O.E., Gram L., Johnsen A.H., Andersson E., Bangsboll S., Tjabringa G.S., Hiemstra P.S., Malm J., Egesten A., and Borregaard N. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J. Biol. Chem. 278 (2003) 28540-28546
57. Starner T.D., Agerberth B., Gudmundsson G.H., and McCray Jr. P.B. Expression and activity of beta-defensins and LL-37 in the developing human lung. J. Immunol. 174 (2005) 1608-1615
58. Suzuki K., and Bakaletz L.O. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect. Immun. 62 (1994) 1710-1718
59. Swanson K., Gorodetsky S., Good L., Davis S., Musgrave D., Stelwagen K., Farr V., and Molenaar A. Expression of a beta-defensin mRNA, lingual antimicrobial peptide, in bovine mammary epithelial tissue is induced by mastitis. Infect. Immun. 72 (2004) 7311-7314
60. Tack B.F., Sawai M.V., Kearney W.R., Robertson A.D., Sherman M.A., Wang W., Hong T., Boo L.M., Wu H., Waring A.J., and Lehrer R.I. SMAP-29 has two LPS-binding sites and a central hinge. Eur. J. Biochem. 269 (2002) 1181-1189
61. Tarver A.P., Clark D.P., Diamond G., Russell J.P., Erdjument-Bromage H., Tempst P., Cohen K.S., Jones D.E., Sweeney R.W., Wines M., Hwang S., and Bevins C.L. Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect. Immun. 66 (1998) 1045-1056
62. Teele D.W., Klein J.O., and Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160 (1989) 83-94
63. Termen S., Tollin M., Olsson B., Svenberg T., Agerberth B., and Gudmundsson G.H. Phylogeny, processing and expression of the rat cathelicidin rCRAMP: a model for innate antimicrobial peptides. Cell Mol. Life Sci. 60 (2003) 536-549
64. Tjabringa G.S., Rabe K.F., and Hiemstra P.S. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung. Pulm. Pharmacol. Ther. 18 (2005) 321-327
65. Turner J., Cho Y., Dinh N., Waring A.J., and Lehrer R.I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42 (1998) 2206-2214
66. Wehkamp J., Schmidt K., Herrlinger K.R., Baxmann S., Behling S., Wohlschlager C., Feller A.C., Stange E.F., and Fellermann K. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J. Clin. Pathol. 56 (2003) 352-357
67. Wezyk M.T., and Makowski A. pH of fluid collected from middle ear in the course of otitis media in children. Otolaryngol. Pol. 54 (2000) 131-133
68. Yang Y.H., Zheng G.G., Li G., Zhang X.J., Cao Z.Y., Rao Q., and Wu K.F. Expression of bioactive recombinant GSLL-39, a variant of human antimicrobial peptide LL-37, in Escherichia coli. Protein Exp. Purif. 37 (2004) 229-235
69. Yanisch-Perron C., Vieira J., and Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33 (1985) 103-119
70. Zaiou M., Nizet V., and Gallo R.L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J. Invest. Dermatol. 120 (2003) 810-816
71. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75 (2004) 39-48
72. Zanetti M., Gennaro R., and Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374 (1995) 1-5
73. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 5449-5453
74. Zhao C., Nguyen T., Boo L.M., Hong T., Espiritu C., Orlov D., Wang W., Waring A., and Lehrer R.I. RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey. Antimicrob. Agents Chemother. 45 (2001) 2695-2702